Molina Healthcare Inc (NYSE:MOH)‘s stock had its “underperform” rating reiterated by investment analysts at Credit Suisse Group in a note issued to investors on Friday. They currently have a $53.00 target price on the stock, up from their previous target price of $50.00. Credit Suisse Group’s target price indicates a potential downside of 25.51% from the company’s current price.

Several other equities research analysts have also commented on the company. Zacks Investment Research lowered Molina Healthcare from a “hold” rating to a “sell” rating in a research note on Tuesday. ValuEngine lowered Molina Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday. Jefferies Group LLC restated a “hold” rating and set a $61.00 price target on shares of Molina Healthcare in a research note on Thursday, June 8th. Morgan Stanley assumed coverage on Molina Healthcare in a research note on Tuesday, June 6th. They set an “underweight” rating and a $65.00 price target for the company. Finally, Stifel Nicolaus lowered Molina Healthcare from a “hold” rating to a “sell” rating and upped their price target for the stock from $47.00 to $60.00 in a research note on Wednesday, May 31st. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $59.69.

Molina Healthcare (NYSE MOH) opened at 71.15 on Friday. The firm has a market capitalization of $4.06 billion, a P/E ratio of 38.23 and a beta of 0.91. The firm has a 50-day moving average price of $68.04 and a 200 day moving average price of $56.55. Molina Healthcare has a 52-week low of $42.56 and a 52-week high of $72.15.

COPYRIGHT VIOLATION NOTICE: “Molina Healthcare Inc (NYSE:MOH) Stock Rating Reaffirmed by Credit Suisse Group” was reported by American Banking News and is the property of of American Banking News. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/07/14/molina-healthcare-inc-nysemoh-stock-rating-reaffirmed-by-credit-suisse-group.html.

In related news, insider William Dentino sold 66,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 6th. The stock was sold at an average price of $68.68, for a total value of $4,532,880.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Terry Bayer sold 15,088 shares of the firm’s stock in a transaction that occurred on Wednesday, June 14th. The stock was sold at an average price of $70.00, for a total value of $1,056,160.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 174,042 shares of company stock worth $11,791,712. 6.20% of the stock is currently owned by company insiders.

A number of hedge funds have recently made changes to their positions in the stock. Meadow Creek Investment Management LLC increased its stake in shares of Molina Healthcare by 13.2% in the first quarter. Meadow Creek Investment Management LLC now owns 2,408 shares of the company’s stock valued at $110,000 after buying an additional 280 shares during the last quarter. Glen Harbor Capital Management LLC increased its stake in shares of Molina Healthcare by 13.2% in the first quarter. Glen Harbor Capital Management LLC now owns 2,924 shares of the company’s stock valued at $133,000 after buying an additional 340 shares during the last quarter. Meeder Asset Management Inc. acquired a new stake in shares of Molina Healthcare during the second quarter valued at $136,000. Northwestern Mutual Wealth Management Co. increased its stake in shares of Molina Healthcare by 361.6% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 3,771 shares of the company’s stock valued at $172,000 after buying an additional 2,954 shares during the last quarter. Finally, Advantus Capital Management Inc increased its stake in shares of Molina Healthcare by 2.9% in the first quarter. Advantus Capital Management Inc now owns 5,449 shares of the company’s stock valued at $248,000 after buying an additional 153 shares during the last quarter. 93.05% of the stock is currently owned by hedge funds and other institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.